Literature DB >> 17223738

Cysteine cathepsins: regulators of antitumour immune response.

Natasa Obermajer1, Bojan Doljak, Janko Kos.   

Abstract

Cysteine cathepsins are lysosomal cysteine proteases that are involved in a number of important biological processes, including intracellular protein turnover, propeptide and hormone processing, apoptosis, bone remodelling and reproduction. In cancer, the cathepsins have been linked to extracellular matrix remodelling and to the promotion of tumour cell motility, invasion, angiogenesis and metastasis, resulting in poor outcome of cancer patients; however, cysteine cathepsins are also involved at different levels of the innate and adaptive immune responses. Their best known role in this aspect is their contribution to major histocompatibility complex class II antigen presentation, the processing of progranzymes into proteolytically active forms, cytotoxic lymphocyte self-protection, cytokine and growth factor degradation and, finally, the induction of cytokine expression and modulation of integrin function. This review is focused on the role of cysteine cathepsins in the antitumour immune response and the evaluation of their pro- and anticancer behaviours during the regulation of these processes.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17223738     DOI: 10.1517/14712598.6.12.1295

Source DB:  PubMed          Journal:  Expert Opin Biol Ther        ISSN: 1471-2598            Impact factor:   4.388


  10 in total

1.  Cystatin C deficiency promotes inflammation in angiotensin II-induced abdominal aortic aneurisms in atherosclerotic mice.

Authors:  Stephanie Schulte; Jiusong Sun; Peter Libby; Lindsey Macfarlane; Chongxiu Sun; Marco Lopez-Ilasaca; Guo-Ping Shi; Galina K Sukhova
Journal:  Am J Pathol       Date:  2010-05-14       Impact factor: 4.307

Review 2.  New strategies for fluorescent probe design in medical diagnostic imaging.

Authors:  Hisataka Kobayashi; Mikako Ogawa; Raphael Alford; Peter L Choyke; Yasuteru Urano
Journal:  Chem Rev       Date:  2010-05-12       Impact factor: 60.622

Review 3.  Cysteine cathepsins in neurological disorders.

Authors:  Anja Pišlar; Janko Kos
Journal:  Mol Neurobiol       Date:  2013-11-15       Impact factor: 5.590

4.  Cysteine protease cathepsin X modulates immune response via activation of beta2 integrins.

Authors:  Natasa Obermajer; Urska Repnik; Zala Jevnikar; Boris Turk; Marko Kreft; Janko Kos
Journal:  Immunology       Date:  2008-01-11       Impact factor: 7.397

Review 5.  Cysteine cathepsins as regulators of the cytotoxicity of NK and T cells.

Authors:  Milica Perišić Nanut; Jerica Sabotič; Anahid Jewett; Janko Kos
Journal:  Front Immunol       Date:  2014-12-02       Impact factor: 7.561

6.  Neuroinflammation-Induced Upregulation of Glial Cathepsin X Expression and Activity in vivo.

Authors:  Anja Pišlar; Larisa Tratnjek; Gordana Glavan; Nace Zidar; Marko Živin; Janko Kos
Journal:  Front Mol Neurosci       Date:  2020-11-20       Impact factor: 5.639

Review 7.  Single-cell RNA sequencing combined with whole exome sequencing reveals the landscape of the immune pathogenic response to chronic mucocutaneous candidiasis with STAT1 GOF mutation.

Authors:  Xiaodi Lu; Keming Zhang; Weiwei Jiang; Hang Li; Yue Huang; Mingwei Du; Jian Wan; Yanyun Cao; Lin Du; Xiaogang Liu; Weihua Pan
Journal:  Front Immunol       Date:  2022-09-15       Impact factor: 8.786

8.  Regulation of split anergy in natural killer cells by inhibition of cathepsins C and H and cystatin F.

Authors:  Špela Magister; Han-Ching Tseng; Vickie T Bui; Janko Kos; Anahid Jewett
Journal:  Oncotarget       Date:  2015-09-08

9.  Upregulation of Cysteine Protease Cathepsin X in the 6-Hydroxydopamine Model of Parkinson's Disease.

Authors:  Anja Pišlar; Larisa Tratnjek; Gordana Glavan; Marko Živin; Janko Kos
Journal:  Front Mol Neurosci       Date:  2018-11-02       Impact factor: 5.639

Review 10.  New Insights into the Role of Cysteine Cathepsins in Neuroinflammation.

Authors:  Anja Pišlar; Lara Bolčina; Janko Kos
Journal:  Biomolecules       Date:  2021-11-30
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.